165 related articles for article (PubMed ID: 37357781)
1. Hypersensitivity to gadolinium-based contrast.
Sáenz de Santa María R; Labella M; Bogas G; Doña I; Torres MJ
Curr Opin Allergy Clin Immunol; 2023 Aug; 23(4):300-306. PubMed ID: 37357781
[TBL] [Abstract][Full Text] [Related]
2. Allergic-like Hypersensitivity Reactions to Gadolinium-based Contrast Agents: An 8-year Cohort Study of 154 539 Patients.
Ahn YH; Kang DY; Park SB; Kim HH; Kim HJ; Park GY; Yoon SH; Choi YH; Lee SY; Kang HR
Radiology; 2022 May; 303(2):329-336. PubMed ID: 35191737
[TBL] [Abstract][Full Text] [Related]
3. Breakthrough Hypersensitivity Reactions to Gadolinium-based Contrast Agents and Strategies to Decrease Subsequent Reaction Rates: A Systematic Review and Meta-Analysis.
Walker DT; Davenport MS; McGrath TA; McInnes MDF; Shankar T; Schieda N
Radiology; 2020 Aug; 296(2):312-321. PubMed ID: 32427558
[TBL] [Abstract][Full Text] [Related]
4. Preventive Effect of Changing Contrast Media in Patients With A Prior Mild Immediate Hypersensitivity Reaction to Gadolinium-Based Contrast Agent.
Ryoo CH; Choi YH; Cheon JE; Yoon SH; Kang HR; Park SJ; Lee W
Invest Radiol; 2019 Oct; 54(10):633-637. PubMed ID: 31033674
[TBL] [Abstract][Full Text] [Related]
5. Hypersensitivity reactions to gadolinium-based contrast agents.
Fok JS; Smith WB
Curr Opin Allergy Clin Immunol; 2017 Aug; 17(4):241-246. PubMed ID: 28537933
[TBL] [Abstract][Full Text] [Related]
6. Subsequent MRI of pediatric patients after an adverse reaction to Gadolinium-based contrast agents.
Hojreh A; Peyrl A; Bundalo A; Szepfalusi Z
PLoS One; 2020; 15(4):e0230781. PubMed ID: 32243440
[TBL] [Abstract][Full Text] [Related]
7. Insight into the dynamic of gadolinium based contrast agent (GBCA) hypersensitivity: Acquisition, persistence and disappearance.
Boehm I; Hungerbühler M; Heverhagen JT
Magn Reson Imaging; 2018 Jun; 49():1-3. PubMed ID: 29247752
[TBL] [Abstract][Full Text] [Related]
8. Empiric Switching of Gadolinium-Based Contrast Agents in Patients With History of Previous Immediate Hypersensitivity Reaction to GBCA: A Prospective Single-Center, Single-Arm Efficacy Trial.
Walker D; McGrath TA; Glikstein R; Chakraborty S; Blanchette C; Schieda N
Invest Radiol; 2021 Jun; 56(6):369-373. PubMed ID: 33337738
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology of Immediate Reactions to Injectable Gadolinium-based Contrast Agents.
Carr TF
Top Magn Reson Imaging; 2016 Dec; 25(6):265-268. PubMed ID: 27748716
[TBL] [Abstract][Full Text] [Related]
10. Immediate Allergic Reactions to Gadolinium-based Contrast Agents: A Systematic Review and Meta-Analysis.
Behzadi AH; Zhao Y; Farooq Z; Prince MR
Radiology; 2018 Feb; 286(2):471-482. PubMed ID: 28846495
[TBL] [Abstract][Full Text] [Related]
11. Assessment of immediate and non-immediate hypersensitivity contrast reactions by skin tests and provocation tests: A review.
Bansie RD; Karim AF; van Maaren MS; Hermans MA; van Daele P; Gerth van Wijk R; Rombach SM
Int J Immunopathol Pharmacol; 2021; 35():20587384211015061. PubMed ID: 34053316
[TBL] [Abstract][Full Text] [Related]
12. Preventing Allergic Reactions to Gadolinium-Based Contrast Agents.
Heshmatzadeh Behzadi A; Prince MR
Top Magn Reson Imaging; 2016 Dec; 25(6):275-279. PubMed ID: 27748715
[TBL] [Abstract][Full Text] [Related]
13. Skin Test Results and Cross-Reactivity Patterns in IgE- and T-Cell-Mediated Allergy to Gadolinium-Based Contrast Agents.
Grueber HP; Helbling A; Joerg L
Allergy Asthma Immunol Res; 2021 Nov; 13(6):933-938. PubMed ID: 34734510
[TBL] [Abstract][Full Text] [Related]
14. Clinical validation of the basophil activation test in immediate hypersensitivity reactions to gadolinium-based contrast agents.
Cabrera CM; Clarcast M; Palacios-Cañas A
Int Immunopharmacol; 2023 Apr; 117():110000. PubMed ID: 37012878
[TBL] [Abstract][Full Text] [Related]
15. Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
Lohrke J; Frisk AL; Frenzel T; Schöckel L; Rosenbruch M; Jost G; Lenhard DC; Sieber MA; Nischwitz V; Küppers A; Pietsch H
Invest Radiol; 2017 Jun; 52(6):324-333. PubMed ID: 28323657
[TBL] [Abstract][Full Text] [Related]
16. Acute Reactions to Gadolinium-Based Contrast Agents in a Pediatric Cohort: A Retrospective Study of 16,237 Injections.
McDonald JS; Larson NB; Kolbe AB; Hunt CH; Schmitz JJ; Kallmes DF; McDonald RJ
AJR Am J Roentgenol; 2021 May; 216(5):1363-1369. PubMed ID: 32755216
[No Abstract] [Full Text] [Related]
17. Safety of Intrathecal Administration of Gadolinium-based Contrast Agents: A Systematic Review and Meta-Analysis.
Patel M; Atyani A; Salameh JP; McInnes M; Chakraborty S
Radiology; 2020 Oct; 297(1):75-83. PubMed ID: 32720867
[TBL] [Abstract][Full Text] [Related]
18. Intraindividual Analysis of Signal Intensity Changes in the Dentate Nucleus After Consecutive Serial Applications of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
Radbruch A; Weberling LD; Kieslich PJ; Hepp J; Kickingereder P; Wick W; Schlemmer HP; Bendszus M
Invest Radiol; 2016 Nov; 51(11):683-690. PubMed ID: 27495187
[TBL] [Abstract][Full Text] [Related]
19. Adverse Events Associated with Intra-Arterial Administration of Gadolinium-Based Contrast Agents: A Systematic Review and Meta-Analysis.
MacLeod CA; Gauthier I; Davenport MS; McGrath TA; Khan F; Dos Santos MP; McInnes MDF; Schieda N
J Vasc Interv Radiol; 2023 Apr; 34(4):568-577.e10. PubMed ID: 36464013
[TBL] [Abstract][Full Text] [Related]
20. Hypersensitivity to Gadolinium-Based Contrast Media.
Gracia Bara MT; Gallardo-Higueras A; Moreno EM; Laffond E; Muñoz Bellido FJ; Martin C; Sobrino M; Macias E; Arriba-Méndez S; Castillo R; Davila I
Front Allergy; 2022; 3():813927. PubMed ID: 35386665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
